<code id='9CA57F5665'></code><style id='9CA57F5665'></style>
    • <acronym id='9CA57F5665'></acronym>
      <center id='9CA57F5665'><center id='9CA57F5665'><tfoot id='9CA57F5665'></tfoot></center><abbr id='9CA57F5665'><dir id='9CA57F5665'><tfoot id='9CA57F5665'></tfoot><noframes id='9CA57F5665'>

    • <optgroup id='9CA57F5665'><strike id='9CA57F5665'><sup id='9CA57F5665'></sup></strike><code id='9CA57F5665'></code></optgroup>
        1. <b id='9CA57F5665'><label id='9CA57F5665'><select id='9CA57F5665'><dt id='9CA57F5665'><span id='9CA57F5665'></span></dt></select></label></b><u id='9CA57F5665'></u>
          <i id='9CA57F5665'><strike id='9CA57F5665'><tt id='9CA57F5665'><pre id='9CA57F5665'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:9294
          Alastair Grant/AP

          LONDON — AstraZeneca said Tuesday it would acquire Fusion Pharmaceuticals in a deal worth more than $2 billion, picking up a company focused on the booming area of targeted radiation therapies for cancer.

          AstraZeneca will pay $2 billion in cash upfront for Fusion, a price that at $21 a share is nearly double Fusion’s closing share price on Monday. If certain regulatory milestones are met, AstraZeneca will pay another $3 a share, or roughly $400 million.

          advertisement

          Fusion specializes in developing radiopharmaceuticals, also known as radioconjugates or radioligands, which deliver radiation directly to tumors, guided by particular markers on cancer cells. The aim is not only to minimize the risk of damaging surrounding, healthy tissue, but also to reach tumors that traditional radiation can’t. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Cytokinetics CEO stresses company can launch heart drug on its own
          Cytokinetics CEO stresses company can launch heart drug on its own

          CytokineticsCEORobertBlumspokeThursdayatatalkduringSTAT’sBreakthroughSummitWestinSanFrancisco.SarahG

          read more
          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more

          Food makers to regulators: Ultra

          Foodmakersdon'twantregulatorstofocusonultra-processedfoodswhentheygotoupdatedietaryguidelines.DanKit